Our client, is an innovative biotechnology organization operating at the forefront of biopharmaceutical discovery. Driven by advanced technology platforms and robust research capabilities, the company empowers global healthcare and life sciences partners to accelerate the development of next-generation biotherapeutics.
To support their rapid commercial scaling, we are seeking a results-driven Business Development Manager based in Hong Kong or Mainland China. This role is tailored for a connected commercial professional with a deep network within Mainland Chinese pharmaceutical companies focused on antibody discovery, therapeutic proteins, and biologics development.
about the job.
- Identify, pursue, and secure high-value business development opportunities and contract research partnerships across Mainland China's biopharmaceutical sector.
- Connect specifically with R&D leaders, decision-makers, and procurement teams within Chinese pharma companies actively developing antibodies, ADCs, and complex therapeutic biologics.
- Manage the complete BD life cycle—from cold outreach and technical discovery meetings to deal structuring, contract negotiation, and closing.
- Utilize existing industry contacts and relationships to rapidly expand the company's pipeline and service agreements.
- Monitor Chinese biopharma trends, pipeline shifts, and therapeutic demands to align the company's platform offerings with market needs.
- Partner closely with internal R&D, scientific support, and executive leadership to present tailored technical proposals and deliver seamless post-award account transition.
- Represent the company at key biopharma conferences, scientific symposiums, and bioprocess exhibitions across China.
skills & experiences required.
- Bachelor’s degree or above in Molecular Biology, Biochemistry, Biotechnology, Pharmacology, or a related Life Sciences discipline (Master's or PhD is a distinct advantage).
- Minimum of 3–6 years of successful sales, business development, or licensing experience within the CRO/CDMO, biotech, or biopharmaceutical industry.
- Proven, active network of R&D directors, scientists, and business leaders within Mainland Chinese pharmaceutical and biotech companies focused on antibody and biologics pipelines.
- Solid understanding of antibody discovery platforms, biologics R&D workflows, and therapeutic protein engineering.
- Demonstrated history of meeting or exceeding commercial quotas and closing complex B2B service or platform agreements.
- Professional fluency in Mandarin and English (spoken and written) is mandatory to engage both Chinese clients and international internal stakeholders.
- Willingness to travel frequently across major biopharma hubs in Mainland China (e.g., Shanghai, Suzhou, Beijing, Guangzhou).
